Expression of bcl‐2 oncogene protein is prevalent in small cell lung carcinomas

The Journal of Pathology

Volumn 177, Issue 2, 1995, Pages 135-138

  Jiang, Shi‐Xu ^a   Sato, Yuichi ^a   Kuwao, Sadahito ^a   Kameya, Toru ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

bcl 2; immunohistochemistry; small cell lung carcinoma

Indexed keywords

ARTICLE; AUTOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL;

CARCINOMA, SMALL CELL; GENE EXPRESSION; HUMAN; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T;

EID: 0028857747     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711770206     Document Type: Article

References (35)

1. Involvement of the bcl‐2 gene in human follicular lymphoma
2. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
3. Programmed cell death: apoptosis and oncogene
4. Stress‐resistance conferred by high level of bcl‐2α protein in human B lymphoblastoid cell
5. Regulation by bcl‐2, c‐myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation‐competent and ‐defective myeloid leukemic cells
6. bcl‐2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
7. bcl‐2 transgene inhibits T cell death and perturbs thymic self‐censorship
8. bcl‐2 gene transfer increases relative resistance of S49.1 and WEHI 7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
9. Apoptotic cell death induced by c‐myc is inhibited by bcl‐2
10. Apoptosis of lung cancer cells caused by some anti‐cancer agents (MMC, CPT‐11, ADM) is inhibited by bcl‐2
11. Cooperative interaction between c‐myc and bcl‐2 proto‐oncogene
12. bcl‐2 and other genomic alterations in the prognosis of large‐cell lymphoma
13. High expression of bcl‐2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
14. Expression of the protooncogene bcl‐2 in the prostate and its association with emergence of androgen‐independent prostate cancer
15. Expression of the apoptosis‐suppressing protein bcl‐2, in neuroblastoma is associated with unfavorable histology and N‐myc amplification
16. The prevalence of BCL‐2 immuoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status
17. bcl‐2 protein in non‐small‐cell lung carcinoma
18. Expression of the bcl‐2 oncogene protein is not specific for the 14;18 chromosomal translocation
19. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death
20. bcl‐2 expression in adult and embryonic non‐haematopoietic tissues
21. Expression of bcl‐2 in fetal tissues suggests a role in morphogenesis
22. The World Health Organization histological typing of lung tumours. Second edition
23. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice
24. Apoptosis in the development of the immune system: growth factors, clonal selection and bcl‐2
25. The involvement of oncogenes and tumour suppressor genes in the control of apoptosis
26. Expression of bcl‐2 in small cell lung carcinoma cells
27. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural originl
28. Expression of bcl‐2 gene product in neuroblastoma
29. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas
30. Peptide hormone production by adenocarcinomas of the lung; its morphologic basis and histogenetic considerations
31. Relative chemosensitivity of non‐small cell lung cancers (NSCLC) expressing neuroendocrine (NE) cell properties
32. Preliminary report of a prospective trial of neuroendocrine (NE) marker analysis and in vitro drug sensitivity (IVDS) testing in patients (PTS) with non‐small cell lung cancer (NSCLC)
33. bcl‐2 gene promotes haemopoietic cell survival and cooperates with c‐myc to immortalize pre‐B cells
34. 1
35. The molecular biology of lung cancer pathogenesis